Trial Profile
A Phase II Trail of Tetrathiomolybdate in Patients With Hormone Refractory Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Tetrathiomolybdate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 26 Nov 2005 New trial record.